482 related items for PubMed ID: 8988897
1. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Estrada J, Boronat M, Mielgo M, Magallón R, Millan I, Díez S, Lucas T, Barceló B.
N Engl J Med; 1997 Jan 16; 336(3):172-7. PubMed ID: 8988897
[Abstract] [Full Text] [Related]
2. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B.
Clin Endocrinol (Oxf); 2005 Nov 16; 63(5):549-59. PubMed ID: 16268808
[Abstract] [Full Text] [Related]
3. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
Wagenmakers MA, Netea-Maier RT, van Lindert EJ, Timmers HJ, Grotenhuis JA, Hermus AR.
Clin Endocrinol (Oxf); 2009 Feb 16; 70(2):274-80. PubMed ID: 18616702
[Abstract] [Full Text] [Related]
4. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T, Tsushima T, Hizuka N, Odagiri E, Murata Y, Suda T, Takano K.
Endocr J; 2001 Feb 16; 48(1):53-62. PubMed ID: 11403103
[Abstract] [Full Text] [Related]
5. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J, Knappe UJ, Lüdecke DK.
Zentralbl Neurochir; 2003 Feb 16; 64(1):6-11. PubMed ID: 12582940
[Abstract] [Full Text] [Related]
6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
Clin Endocrinol (Oxf); 2004 Apr 16; 60(4):476-83. PubMed ID: 15049963
[Abstract] [Full Text] [Related]
7. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER.
Neurosurgery; 2008 Aug 16; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[Abstract] [Full Text] [Related]
8. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E, Maiter D, Grandin C, Raftopoulos C.
Clin Neurol Neurosurg; 2009 Jun 16; 111(5):442-9. PubMed ID: 19200645
[Abstract] [Full Text] [Related]
9. [Assessment of prognosis factors in the cure of Cushing's disease surgically treated via a +septotransphenoidal approach].
González JD, Gómez JM, Montanya E, Carrera MJ, Villabona C, Acebes JJ, Soler J.
An Med Interna; 1997 Jul 16; 14(7):337-40. PubMed ID: 9410118
[Abstract] [Full Text] [Related]
10. Results of external pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Vicente A, Estrada J, de la Cuerda C, Astigarraga B, Marazuela M, Blanco C, Lucas T, Barceló B.
Acta Endocrinol (Copenh); 1991 Nov 16; 125(5):470-4. PubMed ID: 1661997
[Abstract] [Full Text] [Related]
11. Biochemical predictors of outcome of pituitary surgery for Cushing's disease.
Alwani RA, de Herder WW, van Aken MO, van den Berge JH, Delwel EJ, Dallenga AH, De Jong FH, Lamberts SW, van der Lely AJ, Feelders RA.
Neuroendocrinology; 2010 Nov 16; 91(2):169-78. PubMed ID: 19907141
[Abstract] [Full Text] [Related]
12. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.
Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB, Nieman LK, Chrousos GP.
N Engl J Med; 1994 Sep 08; 331(10):629-36. PubMed ID: 8052272
[Abstract] [Full Text] [Related]
13. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ, Martino J, Masuet C, Montanya E, Soler J.
Acta Neurochir (Wien); 2007 Sep 08; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[Abstract] [Full Text] [Related]
14. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F, Tatai S, Aouali R, Semrouni M, Derome P, Chitour F, Benmiloud M.
J Endocrinol Invest; 1996 Oct 08; 19(9):572-80. PubMed ID: 8957739
[Abstract] [Full Text] [Related]
15. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee GH, Mathias DB, James RA, Kendall-Taylor P.
Clin Endocrinol (Oxf); 2001 May 08; 54(5):617-26. PubMed ID: 11380492
[Abstract] [Full Text] [Related]
16. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
Storr HL, Plowman PN, Carroll PV, François I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO.
J Clin Endocrinol Metab; 2003 Jan 08; 88(1):34-7. PubMed ID: 12519825
[Abstract] [Full Text] [Related]
17. Radiosurgery for Cushing's disease after failed transsphenoidal surgery.
Sheehan JM, Vance ML, Sheehan JP, Ellegala DB, Laws ER.
J Neurosurg; 2000 Nov 08; 93(5):738-42. PubMed ID: 11059652
[Abstract] [Full Text] [Related]
18. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
van Aken MO, de Herder WW, van der Lely AJ, de Jong FH, Lamberts SW.
Clin Endocrinol (Oxf); 1997 Aug 08; 47(2):145-9. PubMed ID: 9302385
[Abstract] [Full Text] [Related]
19. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease.
Devoe DJ, Miller WL, Conte FA, Kaplan SL, Grumbach MM, Rosenthal SM, Wilson CB, Gitelman SE.
J Clin Endocrinol Metab; 1997 Oct 08; 82(10):3196-202. PubMed ID: 9329338
[Abstract] [Full Text] [Related]
20. Risk factors and long-term outcome in pituitary-dependent Cushing's disease.
Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M.
J Clin Endocrinol Metab; 1996 Jul 08; 81(7):2647-52. PubMed ID: 8675592
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
